日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathway

莫斯卡汀通过激活IL13RA2依赖的STAT3抑制作用并减弱WNT3/β-catenin信号通路来抑制血管钙化。

Zhang, Tingting; Zhu, Mengmeng; Ma, Jialing; Liu, Zhenghong; Zhang, Zhidan; Chen, Meijie; Zhao, Yaping; Li, Huaxin; Wang, Shengnan; Wei, Xiaoning; Zhang, Wenwen; Yang, Xiaoxiao; Little, Peter J; Kamato, Danielle; Hu, Hao; Duan, Yajun; Zhang, Baotong; Xiao, Jianbo; Xu, Suowen; Chen, Yuanli

Correction: Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway

更正:恩格列净和利拉鲁肽通过增强Erbb4信号通路改善小鼠HFpEF。

Ni, Xia-Yun; Feng, Xiao-Jun; Wang, Zhi-Hua; Zhang, Yang; Little, Peter J; Cao, Yang; Xu, Suo-Wen; Tang, Li-Qin; Weng, Jian-Ping

Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling

Smad转录因子作为7次跨膜G蛋白偶联受体信号传导的介质

Chia, Zheng-Jie; Kumarapperuma, Hirushi; Zhang, Ruizhi; Little, Peter J; Kamato, Danielle

Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases

GDF15在代谢和心血管疾病中的新兴作用

Tian, Tian; Liu, Monan; Little, Peter J; Strijdom, Hans; Weng, Jianping; Xu, Suowen

Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE (-/-) mice

Aclysiran 是一种靶向 ACLY 的 RNAi 治疗剂,可治疗 ApoE (-/-) 小鼠的高胆固醇血症和动脉粥样硬化。

Chen, Meijie; Little, Peter J; Kong, Sudong; Banach, Maciej; Weng, Jianping; Xu, Suowen

Transforming growth factor-β receptors: versatile mechanisms of ligand activation

转化生长因子-β受体:配体激活的多种机制

Chia, Zheng-Jie; Cao, Ying-Nan; Little, Peter J; Kamato, Danielle

Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery

射血分数保留型心力衰竭(HFpEF)动物模型:从代谢病理生物学到药物发现

Gao, Si; Liu, Xue-Ping; Li, Ting-Ting; Chen, Li; Feng, Yi-Ping; Wang, Yu-Kun; Yin, Yan-Jun; Little, Peter J; Wu, Xiao-Qian; Xu, Suo-Wen; Jiang, Xu-Dong

A novel mouse model of familial combined hyperlipidemia and atherosclerosis.

一种新型的家族性混合型高脂血症和动脉粥样硬化小鼠模型

Chen Mei-Jie, Xu Yi-Tong, Sun Lu, Wang Zhi-Hua, Little Peter J, Wang Li, Xian Xun-de, Weng Jian-Ping, Xu Suo-Wen

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

代谢疾病中蛋白质修饰的靶向治疗:分子机制和靶向疗法

Wu, Xiumei; Xu, Mengyun; Geng, Mengya; Chen, Shuo; Little, Peter J; Xu, Suowen; Weng, Jianping

Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies

非酒精性脂肪性肝病(NAFLD)小鼠模型:发病机制和药物治疗

Fang, Tingyu; Wang, Hua; Pan, Xiaoyue; Little, Peter J; Xu, Suowen; Weng, Jianping